NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
NeoImmuneTech
University Hospital, Lille
Delfi Diagnostics Inc.
Medipol University
University Hospital Padova
Memorial Sloan Kettering Cancer Center
Hoffmann-La Roche
Thomas Jefferson University
Revolution Medicines, Inc.
Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-Henares
Weill Medical College of Cornell University
St. Antonius Hospital
Erasca, Inc.
Revolution Medicines, Inc.
Syndax Pharmaceuticals
Syndax Pharmaceuticals
Beni-Suef University
H. Lee Moffitt Cancer Center and Research Institute
ChineseAMS
Shanghai Pulmonary Hospital, Shanghai, China
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Washington
AVEO Pharmaceuticals, Inc.